Next Article in Journal
Antimicrobial Peptide Conjugated on Graphene Oxide-Containing Sulfonated Polyetheretherketone Substrate for Effective Antibacterial Activities against Staphylococcus aureus
Previous Article in Journal
Lyophilized Lipid Liquid Crystalline Nanoparticles as an Antimicrobial Delivery System
 
 
Review
Peer-Review Record

Management of Intra-Abdominal Infections: The Role of Procalcitonin

Antibiotics 2023, 12(9), 1406; https://doi.org/10.3390/antibiotics12091406
by Brian W. C. A. Tian 1, Vanni Agnoletti 2, Luca Ansaloni 3, Federico Coccolini 4, Francesca Bravi 5, Massimo Sartelli 6, Carlo Vallicelli 7 and Fausto Catena 8,*
Reviewer 1: Anonymous
Reviewer 2:
Antibiotics 2023, 12(9), 1406; https://doi.org/10.3390/antibiotics12091406
Submission received: 1 August 2023 / Revised: 20 August 2023 / Accepted: 30 August 2023 / Published: 4 September 2023

Round 1

Reviewer 1 Report

Procalcitonin [PCT] is a valuable biomarker of sepsis. The diagnosis accuracy and specificity of PCT are higher than those of CRP. However, this manuscript dose not contain new perspectives.

Author Response

Thank you for your feedback. This paper was more of a systematic review, pooling together the sparse data on PCT and its role in managing intra-abdominal infections. A lot of surgeons may use PCT values in routine work; but many dont have a good grasp on the latest full body of evidence. Hence this paper is meant to pool data and give a quick glance and update.

Reviewer 2 Report

Blood tests to be used in the diagnosis of intra-abdominal infections and in guiding antibiotic therapy are important. Procalcitonin is promising in this respect. I think it is a valuable review that will contribute to the literature.

1. Diagnosis of intra-abdominal infections and management of antibiotic therapy are difficult. A compilation of studies in the literature in this area may be helpful to clinicians.

2. Handling intra-abdominal infections under separate headings provided a clearer understanding of the data.

3. The methodology part can be written in more detail. If there are publications that are not included, the reasons can be explained in more detail.

4. The discussion section is descriptive. References are sufficient.

5. In the reviewed articles, if there is a new molecule that can be an alternative to procalcitonin in the management of intra-abdominal infections, it can be mentioned in a few sentences.

 

Author Response

Thank you so much for your feedback. 

the 2 major points that we would like to answer.

1) number of papers. there are quite a number of papers, however, alot of it do not mention abdominal infections. For those that do, it is part of a greater study. The dearth of papers makes it more important and vital that a review like our paper is published, so that others can have a sense on the latest data. but it would be hard to perform a thorough PRISMA based SR or even a MA. 

 

2) we purposefully avoided other biomarkers because apart from CRP, the rest are poorly studied. Even more scarce data than PCT.

Reviewer 3 Report

See comments in the manuscript

Comments for author File: Comments.pdf

Author Response

thank you. we have made adjustments in certain areas, taking into account other reviewers' and the managing editors' feedback.

Round 2

Reviewer 1 Report

PCT is a well-known biomarker of sepsis and can help in making early clinical decisions regarding management of patients.However, this manuscript dose not contain new perspectives.

Back to TopTop